UNCY CIK: 1766140

Unicycive Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.77
FY22:
−15.7
FY23:
−18.3
FY24:
−28.6
FY25:
−31.3
Change from FY21 to FY25
millions USD
FY21:
−0.03
FY22:
0.00
FY23:
−0.01
FY24:
−0.07
FY25:
−12.1
Change from FY21 to FY25
millions USD
FY21:
22.4
FY22:
−0.47
FY23:
27.5
FY24:
45.1
FY25:
46.5
millions USD
FY21:
16.6
FY22:
−16.1
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.80
FY22:
−15.7
FY23:
−18.3
FY24:
−28.6
FY25:
−31.3

All amounts in millions USD Data source:SEC EDGAR